carbidopa and Breast Neoplasms

carbidopa has been researched along with Breast Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
An, X; Bhutia, YD; Chen, H; Chen, R; Chen, Z; Chu, M; Ganapathy, V; Huang, H; Kim, K; Kou, L; Sun, M; Xia, X; Yao, Q; Zhang, H1
Amaro, F; Duarte, D; Fresco, P; Gonçalves, J; Oliveira, JC; Reguengo, H; Silva, D; Silva, I; Vale, N1
Jenner, PG; Jones, MK; Ramsay, ID1
Ward, HW1

Trials

1 trial(s) available for carbidopa and Breast Neoplasms

ArticleYear
Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
    Clinical oncology, 1977, Volume: 3, Issue:1

    Topics: Aged; Breast Neoplasms; Bromocriptine; Carbidopa; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Levodopa; Middle Aged; Nausea; Prolactin; Remission, Spontaneous; Stilbenes; Tamoxifen; Time Factors; Vomiting

1977

Other Studies

3 other study(ies) available for carbidopa and Breast Neoplasms

ArticleYear
Carbidopa suppresses estrogen receptor-positive breast cancer via AhR-mediated proteasomal degradation of ERα.
    Investigational new drugs, 2022, Volume: 40, Issue:6

    Topics: Animals; Breast Neoplasms; Carbidopa; Cell Line, Tumor; Estrogen Receptor alpha; Estrogens; Female; Humans; Mice; Parkinson Disease; Receptors, Aryl Hydrocarbon; Receptors, Estrogen

2022
Carbidopa Alters Tryptophan Metabolism in Breast Cancer and Melanoma Cells Leading to the Formation of Indole-3-Acetonitrile, a Pro-Proliferative Metabolite.
    Biomolecules, 2019, 08-24, Volume: 9, Issue:9

    Topics: Breast Neoplasms; Carbidopa; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Female; Humans; Indoles; Melanoma; Skin Neoplasms; Spectrometry, Mass, Electrospray Ionization; Tryptophan

2019
The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.
    British journal of clinical pharmacology, 1978, Volume: 5, Issue:5

    Topics: Adult; Aged; Breast Neoplasms; Carbidopa; Dihydroxyphenylalanine; Female; Growth Hormone; Humans; Hydrazines; Levodopa; Middle Aged; Prolactin; Thyroxine; Time Factors

1978